Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Big Pharma Bets Big on China
China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link
Why is Recursion Pharma stock up 100% today By Investing.com
© Reuters Why is Recursion Pharma (RXRX) stock up 100% today Recursion Pharmaceuticals Inc (NASDAQ:) shares are trading more than 100% higher on Wednesday after
Morgan Stanley Maintains Royalty Pharma (RPRX) Overweight Recommendation
Fintel reports that on April 10, 2023, Morgan Stanley maintained coverage of Royalty Pharma (NASDAQ:RPRX) with a Overweight recommendation. Analyst Price Forecast Suggests 48.83% Upside
Unusual Call Option Trade in Ocuphire Pharma (OCUP) Worth $172.00K
On April 5, 2023 at 10:58:01 ET an unusually large $172.00K block of Call contracts in Ocuphire Pharma (OCUP) was sold, with a strike price
Bayer’s New American CEO to Study Wounded Pharma Giant Before Acting
Business Europe Bill Anderson aims to drive innovation and cultural change and lauds ‘compelling logic’ of Monsanto acquisition Source link
As Ocuphire Pharma Rally Gathers Steam Post-Results, What Did Investors Initially Miss?
Clinical-stage ophthalmic biopharmaceutical company Ocuphire Pharma, Inc. (US:OCUP) announced its fourth-quarter and year-end financial results on March 30, indicating a successful year with significant clinical, regulatory,
Pakistan defers decision on drug price rise as pharma firms struggle By Reuters
3/3 © Reuters. A customer buys medicine from a medical supply store in Karachi, Pakistan February 9, 2023. REUTERS/Akhtar Soomro 2/3 By Ariba Shahid and
J&J's $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion
The healthcare giant’s separation of its consumer-health business arms it with billions in cash for allocating capital in the remaining businesses. Source link